BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Institute for Bioengineering of Catalonia
X-ORIGINAL-URL:https://ibecbarcelona.eu/es/
X-WR-CALDESC:Eventos para Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20191031T110000
DTEND;TZID=Europe/Madrid:20191031T130000
DTSTAMP:20260425T222805
CREATED:20191024T152934Z
LAST-MODIFIED:20191024T152934Z
UID:68918-1572519600-1572526800@ibecbarcelona.eu
SUMMARY:Round Table - 3D Printing in healthcare
DESCRIPTION:On Thrusday 31st we will have the opportunity to learn from the Prof. Axel Guenther (University of Toronto) and from Dr. Tamer Mohamed (Aspect Biosystems Ltd.)\, the latest results obtained in 3D Printing applied to healthcare overseas and how they envision the future of this technology. Opportunities and limitations in the academia and in the industry. \nDr. Tamer Mohamed\, Chief Executive Officer – Aspect Biosystems Ltd.\nTamer Mohamed\, CEO\, Sam Wadsworth\, CSO and Elli Käpylä\, Aspect’s Manager of Academic Alliances and Business Development Manager for Europe\, she is biomedical engineer and expert scientist in materials and 3D printing and tissue models at Aspect Biosystems. Aspect Biosystems is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. Their company is built on over 10 years of research and development and formed through a collaboration between world-class research groups in Engineering and Medicine at the University of British Columbia. Their proprietary Lab-on- a-Printer™ platform technology is enabling advances in understanding fundamental biology\, disease research\, development of novel therapeutics\, and regenerative medicine. They are focused on strategically partnering with pharmaceutical and biotechnology companies\, as well as academic researchers\, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate drug discovery and development and enable the creation of cutting-edge tissue therapies of the future. \n  \nProf. Axel Goünter\, Professor at Faculty of Applied Science & Engineering – University of Toronto\nDr. Guenther is an Associate Professor in the Department of Mechanical and Industrial Engineering\, with cross-appointment at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. He obtained his doctoral degree from ETH Zurich and conducted postdoctoral research at the Massachusetts Institute of Technology. He received the ETH medal (2002)\, the Ontario Early Researcher Award (2009)\, the I.W. Smith Award of the Canadian Society of Mechanical Engineers (2010) and the Innovator of the Year Award of the University of Toronto (2013). He co-invented several bioprinting technologies\, was previously the Scientific Director of the Centre for Microfluidic Systems in Chemistry and Biology (2008-2018)\, and the Wallace G. Chalmers Chair of Engineering Design (2012-18). He currently Co-Leads the Canadian Center for Research and Applications in Fluidic Technologies (CRAFT)\, a collaborative research center between the National Research Council of Canada and the University of Toronto that focuses on device innovation related to the areas of bioprinting\, in-vitro diagnostics and organ-on-chip engineering. \n  \n 
URL:https://ibecbarcelona.eu/es/event/round-table-3d-printing-in-healthcare/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:Other
ORGANIZER;CN="IBEC":MAILTO:www.ibecbarcelona.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20191031T110000
DTEND;TZID=Europe/Madrid:20191031T130000
DTSTAMP:20260425T222805
CREATED:20191024T152934Z
LAST-MODIFIED:20191024T152934Z
UID:96522-1572519600-1572526800@ibecbarcelona.eu
SUMMARY:Round Table - 3D Printing in healthcare
DESCRIPTION:On Thrusday 31st we will have the opportunity to learn from the Prof. Axel Guenther (University of Toronto) and from Dr. Tamer Mohamed (Aspect Biosystems Ltd.)\, the latest results obtained in 3D Printing applied to healthcare overseas and how they envision the future of this technology. Opportunities and limitations in the academia and in the industry. \nDr. Tamer Mohamed\, Chief Executive Officer – Aspect Biosystems Ltd.\nTamer Mohamed\, CEO\, Sam Wadsworth\, CSO and Elli Käpylä\, Aspect’s Manager of Academic Alliances and Business Development Manager for Europe\, she is biomedical engineer and expert scientist in materials and 3D printing and tissue models at Aspect Biosystems. Aspect Biosystems is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. Their company is built on over 10 years of research and development and formed through a collaboration between world-class research groups in Engineering and Medicine at the University of British Columbia. Their proprietary Lab-on- a-Printer™ platform technology is enabling advances in understanding fundamental biology\, disease research\, development of novel therapeutics\, and regenerative medicine. They are focused on strategically partnering with pharmaceutical and biotechnology companies\, as well as academic researchers\, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate drug discovery and development and enable the creation of cutting-edge tissue therapies of the future. \n  \nProf. Axel Goünter\, Professor at Faculty of Applied Science & Engineering – University of Toronto\nDr. Guenther is an Associate Professor in the Department of Mechanical and Industrial Engineering\, with cross-appointment at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. He obtained his doctoral degree from ETH Zurich and conducted postdoctoral research at the Massachusetts Institute of Technology. He received the ETH medal (2002)\, the Ontario Early Researcher Award (2009)\, the I.W. Smith Award of the Canadian Society of Mechanical Engineers (2010) and the Innovator of the Year Award of the University of Toronto (2013). He co-invented several bioprinting technologies\, was previously the Scientific Director of the Centre for Microfluidic Systems in Chemistry and Biology (2008-2018)\, and the Wallace G. Chalmers Chair of Engineering Design (2012-18). He currently Co-Leads the Canadian Center for Research and Applications in Fluidic Technologies (CRAFT)\, a collaborative research center between the National Research Council of Canada and the University of Toronto that focuses on device innovation related to the areas of bioprinting\, in-vitro diagnostics and organ-on-chip engineering. \n  \n 
URL:https://ibecbarcelona.eu/es/event/round-table-3d-printing-in-healthcare-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:Other
ORGANIZER;CN="IBEC":MAILTO:www.ibecbarcelona.eu
END:VEVENT
END:VCALENDAR